Your browser doesn't support javascript.
loading
[THE VALUE OF MUSCLE BIOPSY IN PATIENTS WITHOUT WEAKNESS, HIGH CREATINE KINASE OR MYOPATHY ON ELECTROMYOGRAPHY].
Dori, Amir; Shelestovich, Natalia; Gayster, Alexandra; Lebedyev, Alexander; Berger, Yaniv; Rosin, Dan.
Afiliação
  • Dori A; Department of Neurology, Sheba Medical Center, Tel Hashomer, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shelestovich N; Department of Pathology and Surgery, Sheba Medical Center, Tel Hashomer, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Gayster A; Department of Pathology and Surgery, Sheba Medical Center, Tel Hashomer, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Lebedyev A; Department of Transplantation, Sheba Medical Center, Tel Hashomer, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Berger Y; Department of Transplantation, Sheba Medical Center, Tel Hashomer, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Rosin D; Department of Transplantation, Sheba Medical Center, Tel Hashomer, affiliated with Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Harefuah ; 158(6): 372-377, 2019 Jun.
Article em He | MEDLINE | ID: mdl-31215189
ABSTRACT

INTRODUCTION:

Muscle biopsy is an important diagnostic procedure for the evaluation of neuromuscular disorders, commonly employed when patients present with muscle weakness, high creatine-kinase or electromyography which suggest myopathy. The diagnostic value of this procedure when these are normal is unclear.

AIMS:

To characterize the pathology in muscle biopsies of patients without clinical, laboratory or electromyographic suggestion for myopathy.

METHODS:

Retrospective chart and pathology review of consecutive patients who were evaluated by muscle biopsy at Sheba Medical Center.

RESULTS:

Of 109 patients, 12 (11%) had no indication for myopathy prior to biopsy. Pathology was identified in 2/3 of cases. Inflammation was detected in 5 cases (42%), with a perivascular infiltrate in four, and endomysial in one. A mild myopathy was present in 3/5 of these cases. Type-2 muscle fiber atrophy as the primary or only pathology was seen in 2 cases (17%) and mild neurogenic changes in one (8%). A history of systemic disease, additional laboratory tests or imaging suggestive for inflammation were predictive for inflammatory pathology in 4/5 of cases (P = 0.006).

CONCLUSIONS:

Perivascular inflammation without significant muscle fiber damage is common and meaningful in patients with inflammatory conditions in spite of normal evaluation for myopathy.

DISCUSSION:

Muscle disease is characterized by damage to muscle fibers, connective tissue or vessels. In the absence of fiber damage, muscle strength, creatine-kinase and electromyography may remain normal. These tests therefore do not rule-out perivascular inflammation and mild myopathy. Muscle biopsy is effective for the detection of inflammation in patients with inflammatory conditions in spite of normal strength creatine-kinase and electromyography.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biópsia / Doenças Musculares Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: He Revista: Harefuah Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biópsia / Doenças Musculares Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: He Revista: Harefuah Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel